Lanean...

An Update on Autoantibodies in Scleroderma

Continued advances in the study of scleroderma antibody specificties has led to important insights into disease pathogenesis and clinical subgrouping. These advances include newly described specificities, functional antibodies, and an emerging understanding of the cancer-scleroderma relationship.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Curr Opin Rheumatol
Egile Nagusiak: Mecoli, Christopher A., Casciola-Rosen, Livia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546089/
https://ncbi.nlm.nih.gov/pubmed/30148799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BOR.0000000000000550
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!